Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 10Recruiting 7Active not recruiting 6Terminated 4Unknown 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 11Breast 3Thoracic 2Plasma cell 2Lymphoid 2Gynecologic 2Genitourinary 2Other neoplasm 1Other hematologic neoplasm 1Head & Neck 1CNS 1

Conditions

Prostatic Neoplasms 1Gallbladder Cancer Unresectable 1

Interventions

Docetaxel 33Radiosurgery 22Radiotherapy 21Sunitinib 20pembrolizumab 17Gemcitabine 16Cisplatin 16Androgen Antagonists 15enzalutamide 13Nivolumab 13Goserelin 12Blood Specimen Collection 12aldesleukin 11Surveys and Questionnaires 11Prednisone 11Leuprolide 11Cyclophosphamide 11Abiraterone Acetate 11Bevacizumab 10bicalutamide 9Multiparametric Magnetic Resonance Imaging 9Carboplatin 9acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 8Gonadotropin-Releasing Hormone 8Filgrastim 8Epirubicin 8Chemotherapy, Adjuvant 8Brachytherapy 8toripalimab 7tislelizumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Observation × Genitourinary × Clear all
NCT05493956 2022-09-09

RACE-GB

Sanjay Gandhi Postgraduate Institute of Medical Sciences

Phase NA Unknown
120 enrolled
GastrointestinalGenitourinary

Gallbladder Cancer Unresectable

NCT03893123 2020-03-04

Prostate Cancer Risk in Firefighters

Oslo University Hospital

Unknown
4,500 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡